LSTA

SEC filing LSTA Amends $4.00 Per Share Merger Deal with Kuva Labs, Adds $3.00 Contingent Value Rights for Milestones

4d ago

News Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research

14d ago

Scanner Unusual buy pressure (3.4x avg, 65% up-volume, +22.3% / +0.92 intraday, above VWAP)

87d ago

SEC filing LSTA to be Acquired by Kuva Labs in Tender Offer and Short-Form Merger under Delaware Law

94d ago

News $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA

125d ago

SEC filing LSTA Terminates $200M License Deal with Qilu Pharmaceutical

126d ago

News Why Is Lisata Therapeutics Stock Gaining Today?

132d ago

News BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX)

132d ago

News Lisata Therapeutics to be acquired by Kuva Labs in $4.00-per-share cash deal

132d ago